TOLLAND, Conn., Oct. 3 Nerac Medical Device Analyst PerryDe Fazio will discuss how medical device companies can assess whether a newtechnology will disrupt the market during an MDM Webinar at 2 p.m. EDT Oct. 8,2008. He also will reveal how companies can identify emerging technologiesthat present potential business opportunities.
When to invest in a technology as it emerges is a critical question thatcan affect a company's future. De Fazio will examine three important trendsand emerging technologies and how they will impact the medical device industryin the future:
To register for the free one-hour webinar, please visithttp://www.nerac.com/nerac_insights.php?category=podcasts&id=112.
As a Nerac analyst, De Fazio provides companies in the medical deviceindustry with insight into the potential of untapped markets and disruptivetechnologies. From multi-billion-dollar multinationals to small start-ups, headvises innovators on the development of new technologies and helps vettechnologies for license and acquisition. Mr. De Fazio has nine years ofindustry experience as a project engineer at Boston Scientific Corporation, anR&D engineer at Tissuelink Medical, and a senior engineer at Ortheon Medical.
MDMwebinars.com provides free, live and on-demand webinars for the medicalmanufacturing industry. The webinars are produced by Canon Communications, themedical manufacturing industry's leading publisher, conference and trade eventproducer and digital media company.
Nerac Inc., based in Tolland, CT, is a research and advisory firm forcompanies developing innovative products and technologies. Nerac Analystsdeliver custom assessments of product and technology developmentopportunities, competitor intelligence, intellectual property strategies, andcompliance requirements through a proven blended approach to custom analysis:review of technical knowledge, investigation of intellectual property, andappraisal of business impacts. Nerac deploys analysts in diverse disciplinesto help clients discover new applications, serving as a catalyst for newthinking and creative approaches to business problems or identifying strategicgrowth opportunities. On the web at http://www.nerac.com.-- Breakthroughs and potential applications of nanotechnology -- Technologies to monitor as FDA and supply chain stakeholders move toward implementing Unique Device Indentifiers, or UDIs -- Advances in minimally invasive surgeries and technological factors influencing natural orifice surgery
SOURCE Nerac Inc.